34 Innovative Medical Device Projects Showcase China's Advancements in Surgical Robotics, Ophthalmic OCT, and Companion Diagnostics at 2018 China Medical Device Innovation and Entrepreneurship Conference
Autumn in Beijing is exceptionally beautiful—so breathtakingly lovely that one finds it difficult to know where to begin in praising this ancient city, rich in civilization and imbued with a contemporary spirit. This weekend, the grand convening of the “2018 China Medical Device Innovation and Entrepreneurship Conference” has further adorned Beijing with exceptional splendor.
VCBeat (WeChat ID: vcbeat) has learned that on November 3, 2018, the “2018 China Medical Device Innovation and Entrepreneurship Conference” was grandly held at the Conference Center of Zhongguancun National Independent Innovation Demonstration Zone in Beijing.More than 300 medical professionals from the fields of scientific research, clinical practice, industry, and investment attended the conference. Gathering together, they discussed the cross-sector integration of resources in the medical device industry, facilitated the alignment of innovation and clinical applications with capital, promoted the translation of innovative medical device achievements, and continuously advanced “mass entrepreneurship and innovation” initiatives to implement an innovation-driven development strategy.
The conference was divided into three concurrent sessions: Intelligent Medical Devices, Advanced Therapeutics, and In Vitro Diagnostics.Thirty-four innovative projects, including orthopedic surgical robots, flow fluorescence technology, miniature medical imaging modules, ophthalmic OTC products, domestically produced targeted assay kits, MMC rapid detectors, and minimally invasive intracranial hematoma evacuation systems, participated in the on-site roadshow.Following the final evaluation, three companies, including Anying Technology (Beijing) Co., Ltd., were recognized as the Most Investment-Worthy Projects, and six companies, including Beijing Zhizhen Internet Technology Co., Ltd., were named the Most Investment-Potential Projects.
Furthermore, the conference established channels for industrial resource matchmaking, attracting on-site exhibitions from globally leading medical device service provider NAMSA, Swiss design service provider Helbling, third-party medical device service platform Osida Medical Device Service Group, WuXi AppTec’s Medical Device Testing Services Division, domestic efficient clinical R&D management platform Qingying Medical, specialized medical device industrial park Zhongguancun Medical Device Park, investment and incubation platforms Heyi Guangye Innovation Platform, research institution Beijing Natong Medical Technology Research Institute, as well as innovative project companies such as Huarui, in vitro diagnostics manufacturer Jingtian Medical, and non-invasive arterial blood pressure monitor manufacturers Zhongkang and Hezheng. These participants essentially covered all segments of the industrial ecosystem, including financing and investment, design development and verification, regulatory registration services, and industrial localization and manufacturing (industrial parks). The event aims to facilitate a grand gathering for in-depth exchanges among stakeholders across the entire industry and value chain.
Grand Scene at the Conference
Supported by the Administrative Committee of Haidian Park, Zhongguancun Science Park, this conference is hosted by the Chinese Society of Biomedical Engineering, co-organized by Nankai University and Beijing Natong Technology Group Co., Ltd., and undertaken by the Working Committee on Technological Innovation and Industry Promotion of the Chinese Society of Biomedical Engineering and the Beijing Heyi Guangye Innovation Platform.
Ms. Li Dongming from the Haidian District Government, Director Li Aimin of the Exhibition and Transaction Center of Zhongguancun National Independent Innovation Demonstration Zone, Minister Zhang Xu of the Medical Project Division under the Biomedical Department of the Beijing Municipal Science and Technology Commission, Vice President Wang Guangzhi and Vice President Wan Suiren of the Chinese Society of Biomedical Engineering, and Secretary-General Chi Hui attended the event.
Ms. Li Dongming, Haidian District Government
““We hope that this conference will attract and identify a batch of innovative and entrepreneurial projects with significant clinical value and high translational potential, along with industrial service resources, to establish themselves in Haidian. By maximizing the utilization of the district’s existing intellectual resources and technological reserves, we aim to foster a more robust entrepreneurial ecosystem for industrial development.”At the opening ceremony of the conference, Ms. Li Dongming expressed her earnest hope for promoting the rapid and sustainable development of China's medical device industry in her address.
Ms. Chi Hui, Secretary-General of the Chinese Society of Biomedical Engineering
Ms. Chi Hui, Secretary-General of the Chinese Society for Biomedical Engineering, pointed out that to transform the current fragmented and isolated innovation efforts of individual enterprises into collaborative industry-wide innovation, and to create a synergistic environment within a networked ecosystem, the Society has organized this conference. By leveraging the resource advantages of a national-level academic society, the event brings together expert knowledge and industrial insights to seamlessly address the needs of innovative and entrepreneurial enterprises, thereby facilitating the implementation of a batch of valuable and high-potential projects in medical innovation and clinical translation.
Mr. Dong Xiang, General Manager of the Heyi Guangye Innovation Platform, stated in his address that open, collaborative, and integrated innovation has gradually become the dominant model of innovation and a global development trend. This conference will join hands with domestic and international medical device startups and industry service providers from home and abroad to initiate the restructuring of the medical device industry’s innovation ecosystem, establish a source of original innovation for medical device R&D, and ultimately form a Chinese medical device innovation ecosystem based in Haidian, serving Beijing, and radiating across China.
Professor Gao Xiaorong from the Department of Biomedical Engineering, School of Medicine, Tsinghua University, provides on-site commentary
The expert review panel for this event features an exceptionally strong lineup. Each sub-venue has invited two academic experts, one industry expert, and two investment experts to form the review panel, providing on-site evaluations of projects from diverse perspectives. Distinguished figures from academia, the investment community, and the industry have gathered to serve as judges and guests, including Professor Wan Suiren from Southeast University; Professor Xi Tingfei, Director of the Center for Biomedical Materials and Tissue Engineering at the Academy for Advanced Interdisciplinary Studies, Peking University; Professor Gao Xiaorong from the Department of Biomedical Engineering, School of Medicine, Tsinghua University; Professor Kang Xixiong from the Experimental Diagnosis Center of Beijing Tiantan Hospital; Yang Yigang, Founding Managing Partner of Pengshi Asset Management; Shi Guomin, Managing Director of Huagai Medical Fund; Zhang Peng, Executive Partner of GTJA Capital; Li Changying, Chairman of Aeonmed Co., Ltd.; and Zhu Lei, R&D Director of Ultrasound Imaging Systems at Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
On-site Commentary by Mr. Yang Yigang, Founding Managing Partner of Pengshi Capital
The atmosphere at the event was vibrant, as 34 teams delivered impressive project presentations to the judges and an audience of over 300. Ranging from surgical robots and EEG sensing to tumor companion diagnostics, these astonishing innovative projects ignited the judges’ enthusiasm. They engaged in lively discussions with the presenters and provided objective, professional comments and guidance.
Project Pitch Event
Following nearly seven hours of compelling roadshows, the following companies were respectively recognized as the Most Investment-Worthy Project and the Most Investment-Potential Project:
Furthermore, the Beijing Heyi Guangye Innovation Platform was officially launched for the first time at this conference. As a professional investment incubation platform and the organizer of the event, it presented an industrial service package to the three enterprises recognized as having the highest investment potential, with a signing ceremony held on-site. The Heyi Guangye Innovation Platform is committed to facilitating collaboration between startups and industrial resources, thereby promoting the commercialization of innovative projects. The services offered include intellectual property support, regulatory compliance assistance, and industry mentorship. These services will be individually tailored and delivered by Heyi Guangye professionals, based on the specific technological and product characteristics of each enterprise.
Professor Wan Suiren, Vice Chairman of the Chinese Society of Biomedical Engineering, announced the successful conclusion of the Medical Device Innovation and Entrepreneurship Conference in his closing remarks. He stated, “It is truly gratifying to witness so many outstanding projects today, which offer a glimpse into the promising future of China’s medical device industry. I am confident that, with the support of the Heyi Guangye Innovation Platform and through this roadshow, these projects will be rapidly implemented and make significant contributions to the advancement of healthcare in China.”
Professor Wan Suiren, Vice President of the Chinese Society of Biomedical Engineering
Innovation should not remain confined to concepts and theories; rather, it must translate innovative products and ideas into practical applications, thereby establishing tangible products and industrial chains. The convening of this conference not only showcases China’s latest scientific achievements in medical devices but also effectively links innovative projects with industrial resources, holding significant importance for accelerating the transformation of innovation outcomes.